Studying these pathways is central to understanding tumour cell biology. Dr. Sorensen’s research focuses on targeting these pathways as a treatment strategy, while minimizing effects on normal growth. Dr. Sorensen's team investigates how mutations disrupt signal transduction in solid tumours and leukemias, with the goal of identifying new therapeutic targets.